Global Urolithiasis Management Devices Market Report 2024

The urolithiasis management devices market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.59 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. Historical growth can be attributed to increased healthcare spending and investments in urological care, the aging population contributing to a higher incidence of urolithiasis, the expansion of healthcare infrastructure in developing areas, regulatory approvals and guidelines enhancing safety and efficacy, and sedentary lifestyles.

The urolithiasis management devices market size is expected to see strong growth in the next few years. It will grow to $2.05 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. Forecasted growth can be attributed to increasing awareness of minimally invasive procedures, a growing incidence and recurrence of urolithiasis, ongoing advancements in endoscopic procedures, a shift towards outpatient treatments for cost-effectiveness and shorter hospital stays, and rising patient preference for non-invasive treatment options. Major trends in this forecasted period include ongoing innovation in device technology, a focus on patient comfort and safety, the integration of robotics and artificial intelligence (AI) into urolithiasis management devices, and progress in molecular diagnostics and genetic profiling.

The urolithiasis management devices market is set to experience growth driven by the increasing prevalence of kidney diseases. Kidney disease, also known as renal disease or nephropathy, refers to a condition where the kidneys are damaged and their function is compromised. Factors contributing to the rising prevalence of kidney diseases include increased consumption of animal proteins, sedentary lifestyles, and escalating obesity rates. Urolithiasis management devices enable healthcare professionals to perform precise interventions, alleviate obstruction, prevent complications, and enhance patient outcomes in cases related to urolithiasis-induced kidney issues. For example, Kidney Research UK reported in June 2023 that the incidence of acute kidney injury is expected to rise from around 615,000 episodes in 2022 to approximately 637,000 by 2033. Hence, the increasing prevalence of kidney diseases is fueling the growth of the urolithiasis management devices market.

Key players in the urolithiasis management devices market are focusing on developing innovative technology-based products such as thulium fiber laser (TFL) technology-based laser machines to maintain a competitive advantage. Thulium Fiber Laser (TFL) technology is an advanced laser system utilized in the management and treatment of urolithiasis, or urinary stones. For instance, Coloplast AS launched the Coloplast TFL Drive in July 2023, marking the first laser product capable of pulverizing kidney stones into fine particles. This all-in-one thulium fiber laser system is designed for lithotripsy, BPH (Benign prostatic hyperplasia) treatment, and precise soft tissue procedures, offering faster, safer treatments with surgical versatility and highly effective intra-operative performance using the latest Thulium Fiber Laser (TFL) technology.

In September 2021, Boston Scientific Corporation acquired Lumenis Ltd., aiming to enhance its portfolio of urology and pelvic health solutions by leveraging Lumenis's expertise in minimally invasive surgical technologies. This strategic move enables Boston Scientific to address the evolving needs of patients and healthcare providers in urology, particularly in treating kidney stones, utilizing Lumenis's urolithiasis management devices.

Major companies operating in the urolithiasis management devices market are Medtronic plc, Siemens Healthineers AG, Boston Scientific Corporation, Olympus Corporation, NOVAmedtek, Coloplast Group, Rocamed SAM, DirexGroup, Cook Medical Inc., Karl Storz SE & Co. KG, C. R. Bard Inc., MTS Medical LLC, Richard Wolf GmbH, Wellspect HealthCare, Dornier MedTech GmbH, EDAP TMS, EMS Electro Medical Systems SA, Shenzhen Huikang Medical Apparatus, Storz Medical AG, Allengers Medical Systems, JenaSurgical GmbH, ELMED Medical Systems, Allium Medical Solutions Ltd., Elmed Lithotripsy Systems Inc., Inceler Medikal Co. Ltd.

North America was the largest region in the urolithiasis management devices market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urolithiasis management devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urolithiasis management devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Urolithiasis management devices are medical instruments utilized in diagnosing, treating, and managing urolithiasis, which involves the formation of stones in the urinary tract. They primarily aid in retrieving, breaking, or assisting the passage of kidney stones, offering minimally invasive treatment options. These devices target the challenges associated with kidney stones by providing efficient and less invasive solutions for their management.

The main types of urolithiasis management devices include lithotripters and ureteroscopes. Lithotripters are medical devices that utilize shock waves or laser technology to break kidney stones into smaller fragments, facilitating their passage through the urinary tract. They are used in treatments such as extracorporeal shock wave lithotripsy (ESWL), intracorporeal lithotripsy, percutaneous nephrolithotomy, and others. These devices serve various end users, including hospitals, clinics, and ambulatory surgical centers.

The urolithiasis management devices market research report is one of a series of new reports that provides urolithiasis management devices market statistics, including the urolithiasis management devices industry global market size, regional shares, competitors with urolithiasis management devices market share, detailed urolithiasis management devices market segments, market trends, and opportunities, and any further data you may need to thrive in the urolithiasis management devices industry. This urolithiasis management devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The urolithiasis management devices market consists of sales of nephroscopes, stone retrieval baskets, stone extraction balloons, and ureteral stents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.